These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 27550615)

  • 1. Cholinergic System and Neuroinflammation: Implication in Multiple Sclerosis.
    Di Bari M; Di Pinto G; Reale M; Mengod G; Tata AM
    Cent Nerv Syst Agents Med Chem; 2017; 17(2):109-115. PubMed ID: 27550615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the α7 Nicotinic Acetylcholine Receptor and RIC-3 in the Cholinergic Anti-inflammatory Pathway.
    Treinin M; Papke RL; Nizri E; Ben-David Y; Mizrachi T; Brenner T
    Cent Nerv Syst Agents Med Chem; 2017; 17(2):90-99. PubMed ID: 27573666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation.
    Brenner T; Nizri E; Irony-Tur-Sinai M; Hamra-Amitay Y; Wirguin I
    J Neuroimmunol; 2008 Sep; 201-202():121-7. PubMed ID: 18684515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic modulation of the immune system presents new approaches for treating inflammation.
    Hoover DB
    Pharmacol Ther; 2017 Nov; 179():1-16. PubMed ID: 28529069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible Correlation between Cholinergic System Alterations and Neuro/Inflammation in Multiple Sclerosis.
    Gatta V; Mengod G; Reale M; Tata AM
    Biomedicines; 2020 Jun; 8(6):. PubMed ID: 32521719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cholinergic balance perturbation in neurological diseases.
    Nizri E; Wirguin I; Brenner T
    Drug News Perspect; 2007 Sep; 20(7):421-9. PubMed ID: 17992264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic and purinergic systems: A key to multiple sclerosis?
    Polachini CRN; Spanevello RM; Schetinger MRC; Morsch VM
    J Neurol Sci; 2018 Sep; 392():8-21. PubMed ID: 30097157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulators of cholinergic signaling in disorders of the central nervous system.
    Winek K; Soreq H; Meisel A
    J Neurochem; 2021 Sep; 158(6):1425-1438. PubMed ID: 33638173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating disorders across the lifespan by modulating cholinergic signaling with galantamine.
    Metz CN; Pavlov VA
    J Neurochem; 2021 Sep; 158(6):1359-1380. PubMed ID: 33219523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cholinergic anti-inflammatory pathway: An innovative treatment strategy for neurological diseases.
    Han B; Li X; Hao J
    Neurosci Biobehav Rev; 2017 Jun; 77():358-368. PubMed ID: 28392244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and peripheral anti-inflammatory effects of acetylcholinesterase inhibitors.
    Vaknine S; Soreq H
    Neuropharmacology; 2020 May; 168():108020. PubMed ID: 32143069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies.
    Bjelobaba I; Savic D; Lavrnja I
    Curr Pharm Des; 2017; 23(5):693-730. PubMed ID: 27981909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosterism of Nicotinic Acetylcholine Receptors: Therapeutic Potential for Neuroinflammation Underlying Brain Trauma and Degenerative Disorders.
    Mitra S; Khatri SN; Maulik M; Bult-Ito A; Schulte M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Distinct Subsets of Macrophages in the Pathogenesis of MS and the Impact of Different Therapeutic Agents on These Populations.
    Radandish M; Khalilian P; Esmaeil N
    Front Immunol; 2021; 12():667705. PubMed ID: 34489926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity.
    Halder N; Lal G
    Front Immunol; 2021; 12():660342. PubMed ID: 33936095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors.
    Nizri E; Hamra-Amitay Y; Sicsic C; Lavon I; Brenner T
    Neuropharmacology; 2006 Apr; 50(5):540-7. PubMed ID: 16336980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis.
    Miller ED; Dziedzic A; Saluk-Bijak J; Bijak M
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31284389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic drugs as therapeutic tools in inflammatory diseases: participation of neuronal and non-neuronal cholinergic systems.
    Sales ME
    Antiinflamm Antiallergy Agents Med Chem; 2013; 12(2):109-16. PubMed ID: 23360259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of brain eicosanoid synthetic pathway in multiple sclerosis and in animal models of demyelination: role of cyclooxygenase-2.
    Palumbo S; Bosetti F
    Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):273-8. PubMed ID: 24095587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.